ERBB2 and gastric cancer: Moreover, both patients with HER2-positive breast and HER2-positive gastric cancers, showed a higher incidence of distant metastases located in the central nervous system (CNS) (16, 17), but in HER2-positive SGCs we lack an in-depth analysis of this feature.